Dupont Capital Management’s Envoy Medical COCH Stock Holding History

Dupont Capital Management’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-300,000	Closed	-$3.03M	–	844
2022 Q4	$3.03M	Hold	300,000	–	–	0.14%	102
2022 Q3	$2.95M	Hold	300,000	–	–	0.18%	103
2022 Q2	$2.94M	Hold	300,000	–	–	0.14%	139
2022 Q1	$2.94M	Hold	300,000	–	–	0.12%	157
2021 Q4	$2.92M	Hold	300,000	–	–	0.1%	183
2021 Q3	$2.91M	Hold	300,000	–	–	0.09%	225
2021 Q2	$2.91M	Buy	+300,000	New	+$2.92M	0.07%	254

Other funds holding COCH

AMC

Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Dupont Capital Management's COCH Position: Q1 2023 in Review

Dupont Capital Management sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 300,000 shares — an estimated $3.03M sold.

Dupont Capital Management first reported a position in COCH in Q2 2021 and held it in 7 quarters. The position peaked at $3.03M in Q4 2022. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

Dupont Capital Management reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
Dupont Capital Management sold 300,000 Envoy Medical shares in Q1 2023, an estimated $3.03M.
Dupont Capital Management first reported a position in Envoy Medical in Q2 2021 and held it in 7 quarters.
Dupont Capital Management's Envoy Medical position peaked at $3.03M in Q4 2022.
24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on Dupont Capital Management's 13F filing for Q1 2023, filed 28 Apr 2023.